Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems

A comprehensive review of nanoparticle-based drug systems, including advanced formulations and an emphasis on their pulmonary application

Kamal Dua (Edited by), Philip M. Hansbro (Edited by), Ridhima Wadhwa (Edited by), Mehra Haghi (Edited by), Lisa G. Pont (Edited by), Kylie A. Williams (Edited by)

9780128206584

Paperback, published 7 August 2020

616 pages, 45 illustrations (15 in full color)
23.4 x 19 x 3.8 cm, 1.25 kg

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems explores the development of novel therapeutics and diagnostics to improve pulmonary disease management, looking down to the nanoscale level for an efficient system of targeting and managing respiratory disease. The book examines numerous nanoparticle-based drug systems such as nanocrystals, dendrimers, polymeric micelles, protein-based, carbon nanotube, and liposomes that can offer advantages over traditional drug delivery systems. Starting with a brief introduction on different types of nanoparticles in respiratory disease conditions, the book then focuses on current trends in disease pathology that use different in vitro and in vivo models.

1. Chronic respiratory diseases: An introduction and need for novel drug delivery approaches2. Drug delivery of respiratory medicines in practice3. Advanced drug delivery systems for respiratory diseases4. Novel drug delivery systems and significance in respiratory diseases5. Use of biologics in the treatment of asthma, COPD, ACOS, and idiopathic pulmonary fibrosis6. Targeting biofilms in chronic respiratory infections using drug delivery systems7. Absorption enhancement of macromolecule administered intrapulmonary8. In silico analysis of drug delivery in respiratory disease9. Concepts of nanotechnology in nanomedicine: From discovery to applications10. Advancement in translational respiratory research using nanotechnology 11. Nanoparticle-based macromolecule drug delivery to lungs12. Formulation and role of polymeric and inorganic nanoparticles in respiratory diseases13. Inhalable hybrid nanocarriers for respiratory disorders14. Functionalized nanoparticles in pulmonary disease diagnosis15. Drug delivery system in pulmonary disease: Role of microparticles16. Microparticulate drug delivery systems for targeting respiratory diseases17. Porous particulate platforms for enhanced pulmonary delivery of bioactives18. Liposomes in the treatment of chronic respiratory conditions19. Theranostic drug delivery systems for targeted therapy of lung diseases20. Targeted polymeric miceller systems for respiratory diseases21. Hydrogels for pulmonary drug delivery22. Mucoadhesive drug delivery systems in respiratory diseases23. Targeting lung cancer using advanced drug delivery systems24. Plant-based drug delivery systems in respiratory diseases25. Role of essential oils in respiratory diseases through advanced and nanodrug delivery systems26. Pharmacokinetics and pharmacodynamics of the advanced drug delivery systems

Subject Areas: Materials science [TGM], Biotechnology [TCB], Biomedical engineering [MQW], Medical toxicology [MMGT], Pharmacology [MMG], Respiratory medicine [MJL], Physiology [MFG], Epidemiology & medical statistics [MBNS], Pharmaceutical industries [KNDP]